SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] DEF 14A: (Original Filing)
[]
BSPM [Biostar Pharmaceuticals,] DEF 14A: (Original Filing)
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________]
BSPM [Biostar Pharmaceuticals,] DEF 14A: SCHEDULE 14A x o Check the appropriate box:
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________]
ATAI [ATA] 6-K: (Original Filing)
[ATA Announces Results of Annual General Meeting of Shareholders ATA Inc. (ATA or the Company) (NASDAQ: ATAI) BEIJING, September 21, 2012 Specifically, the shareholders approved: 1. Re-election of Andrew Yan as a class B director of the Company; and 2. Re-appointment of KPMG as the Companys independent auditor for the fiscal year ending March 31, 2013. About ATA Inc.] [ATA Inc. Benson Tsang]
AUO [AU OPTRONICS] CORRESP: September 21, 2012 Via EDGAR Division of Corporation
[September 21, 2012 Via EDGAR Division of Corporation Finance 100 F Street, NE Attn: Mr. Martin James Senior Assistant Chief Accountant Re: AU Optronics Corp. Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 27, 2012 File No. 001-31335 Dear Mr. James: For your convenience, we have included herein the Staffs comment in italics for which supplemental]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] DEF 14A: (Original Filing)
[Skystar Bio-Pharmaceuticalmpany Notice of Annual Meeting and Proxy Statement Annual Meeting to be held on October 25, 2012, at 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China, at 7:45 pm, local timeystar Bio-Pharmaceuticalmpany NOTICE OF ANNUAL MEETING OF SHAREHOLDERS Dear Shareholder:]
AUO [AU OPTRONICS] 6-K: (Original Filing)
[AU Optronics Corp. September 21, 2012 English Language Summary Subject: Statement of AU Optronics Corp. Regulation: Date of Events: 2012/09/21 (Taiwan time) Contents: 1. Parties to the legal matter, name of the court, disposing agency, and reference/case numbers of relevant documents: 2. Date of occurrence of the event: 2012/09/21 (Taiwan time) 3. Background and circumstances of the matter (including the] [Item 1. AU Optronics Corp.]
BSPM [Biostar Pharmaceuticals,] DEF 14A: SCHEDULE 14A x o Check the appropriate box:
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies:______________________________________ (2)gregate number of securities to which transaction applies:______________________________________ (3) (4) Proposed maximumgregate value of transaction: ______________________________________]
